IRLAB Therapeutics doses first patient in pivotal apathy trial
The LIFT-PD study will enroll 75 Parkinson’s patients experiencing apathy across 16 sites in Germany, Bulgaria, Poland and Spain
The LIFT-PD study will enroll 75 Parkinson’s patients experiencing apathy across 16 sites in Germany, Bulgaria, Poland and Spain
During live demonstrations, industry leaders highlighted SEOPRO’s ability to spot portfolio risk, execution bottlenecks, and decision delays early—before they escalate into costly program disruptions
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
The construction projects, which have already begun, will be finalised gradually from the end of 2027 through 202
The TacroType test provides actionable genetic insights to help clinicians understand how individual patients metabolize tacrolimus
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
Under the deal, Vivtex will license select oral drug-delivery technologies to Novo Nordisk
Asahi Kasei is consistently pursuing its strategy of building a focused, sustainable specialty pharmaceutical platform for immunocompromised and medically complex patient groups
Asahi Kasei Pharma receives worldwide exclusive rights for the research, development, manufacturing, and marketing of the active ingredients
For the fourth quarter, revenue surged 47% year-on-year to Rs. 2,510 million, driven by a 23% rise in domestic sales and a 9.3x jump in export sales
Subscribe To Our Newsletter & Stay Updated